Abstract:Fetal growth restriction is a pathological condition occurring when the fetus does not reach the genetically determined growth potential. The etiology of fetal growth restriction is expected to be multifactorial and include fetal, maternal, and placental factors, the latter being the most frequent cause of isolated fetal growth restriction. Severe fetal growth restriction has been related to both an increased risk of perinatal morbidity and mortality, and also a greater susceptibility to developing diseases (especially cardio-metabolic and neurological disorders) later in life. In the last decade, emerging evidence has supported the hypothesis of the Developmental Origin of Health and Disease, which states that individual developmental 'programming' takes place via a delicate fine tuning of fetal genetic and epigenetic marks in response to a large variety of 'stressor' exposures during pregnancy. As the placenta is the maternal-fetal interface, it has a crucial role in fetal programming, such that any perturbation altering placental function interferes with both in-utero fetal growth and also with the adult life phenotype. Several epigenetic mechanisms have been highlighted in modulating the dynamic placental epigenome, including alterations in DNA methylation status, post-translational modification of histones, and non-coding RNAs. This review aims to provide a comprehensive and critical overview of the available literature on the epigenetic background of fetal growth restriction. A targeted research strategy was performed using PubMed, MEDLINE, Embase, and The Cochrane Library up to January 2022. A detailed and fully referenced synthesis of available literature following the Scale for the Assessment of Narrative Review Articles guidelines is provided. A variety of epigenetic marks predominantly interfering with placental development, function, and metabolism were found to be potentially associated with fetal growth restriction. Available evidence on the role of environmental exposures in shaping the placental epigenome and the fetal phenotype were also critically discussed. Because of the highly dynamic crosstalk between epigenetic mechanisms and the extra level of complexity in interpreting the final placental transcriptome, a full comprehension of these phenomenon is still lacking and advances in multi-omics approaches are urgently needed. Elucidating the role of epigenetics in the developmental origins of health and disease represents a new challenge for the coming years, with the goal of providing early interventions and prevention strategies and, hopefully, new treatment opportunities.

Genetics Etiologies Associated with Fetal Growth Restriction

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

The Genetic and Clinical Outcomes in Fetuses With Isolated Fetal Growth Restriction: A Chinese Single-Center Retrospective Study

Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction

Progress in the understanding of the etiology and predictability of fetal growth restriction

Etiologic evaluation and pregnancy outcomes of fetal growth restriction (FGR) associated with structural malformations

Etiology and perinatal outcome of periviable fetal growth restriction associated with structural or genetic anomaly

Fetal genetic findings by chromosomal microarray analysis and karyotyping for fetal growth restriction without structural malformations at a territory referral center: 10-year experience

Is there an increased risk of genetic abnormalities in fetuses with congenital heart disease in the setting of growth restriction?

Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System

Fetal growth restriction: unresolved issues of risk stratification, early diagnosis, and obstetric management

Paediatric consequences of fetal growth restriction

Early judgment of placental dysfunction and its relationship with fetal growth restriction

Molecular regulators of defective placental and cardiovascular development in fetal growth restriction

Severe early-onset fetal growth restriction: What do we tell the prospective parents?

Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade

The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome

Fetal Growth Restriction - Outcome Driven Definition [23H]

Clinical Characteristics and Pregnancy Outcomes of Preeclampsia Complicated with Fetal Growth Restriction

Genome-Wide Analysis in the Study of the Fetal Growth Restriction Pathogenetics

Epigenetics Beyond Fetal Growth Restriction: A Comprehensive Overview